I can’t believe I’ve been selected for the Early Career Investigator Award by @AAHPM ! 🎉 A heartfelt thank you to my amazing mentors, supportive patients and families, and our dedicated palliative care team for making this possible. Feeling honored! 🙏 #AAHPM #PalliativeResearch

Looking for a version of the MoCA that can be administered over the phone and was reminded of the Impossible MoCA, which is always fun to give to anxious colleagues. "Just a standard test I give to all my patients".

🚀 Join Yale's Cutting-Edge Brain & AI Research Team! 🧠✨ Yale's Center for Brain & Mind Health (CBMH) is hiring at all levels to lead innovative AI-driven neuroscience! We're seeking passionate researchers applying AI to brain health challenges. Don’t miss the chance to shape

NIA’s now ex-neuroscience division director falsified/fabricated study results... results that led to clinical trials of the antibody prasinezumab which had no effect on global or imaging measures of Parkinson’s disease progression in a 2022 NEJM paper https://t.co/jLkGSy8GRF

Patients with #Alzheimers disease and #hypertension have an even greater risk of cognitive decline than those with one #riskfactor and not the other, according to a new @AlzDemJournals study led by @NeurologyYale's Adam de Havenon, MD: https://t.co/QTmhJkbpZI

Want to know more about facilitators and barriers to implementation of a Sepsis Transition and Recovery program? A report of our pre-implementation work is now published ⁦@HSRatBMC⁩ Congrats to ⁦@TaraEatonPhD⁩ and team!

Frailty in Medicare Advantage and Traditional Medicare Beneficiaries

For every study that helps us decide whether to start a new medication, there should be an equal & opposite study to help us decide when to stop a medication. With that new law of medicine, I present you this study on beta-blocker discontinuation after MI https://t.co/A4QSC6Unxo

Every Target Trial Emulation Study: "Randomization was emulated using propensity score matching adjusting for baseline covariates" Narrator: this was an observational study where nothing close to randomization was done

In my advanced CKD clinic, this is a common clinical encounter: Mr. Jones is 83 and has chronic kidney failure with a low eGFR. He’s not eligible for a transplant.

Come join our amazing team! I get to work with the best students and colleagues. Spread the word!

🎓 Join Our Team! 🎓 @wakeforestmed is seeking a talented researcher for an open rank, tenure track position in Geroscience. If your work explores the biology of aging and chronic disease, we’d love to hear from you! 💼 Apply now: https://t.co/Pqlc27yY4q @agingup @toddhaberkost

SPRINT showed that intensive lowering of systolic BP increased the risk of incident CKD and episodes of AKI. A study looked at legacy effect of intensive vs. standard systolic BP lowering on longer-term incidence of kidney failure. Rates of dialysis or transplantation were higher

Great work by @priyapalta

The relationship between frailty and social vulnerability: a systematic review - The Lancet Healthy Longevity https://t.co/30TOLUP9Zx @TorrensUni @TheLancet @ElsaDent

𝐖𝐚𝐧𝐭 𝐭𝐨 𝐢𝐧𝐜𝐫𝐞𝐚𝐬𝐞 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥 𝐞𝐧𝐫𝐨𝐥𝐥𝐦𝐞𝐧𝐭? 📊 Learn how @UCSDHealth investigators consented and scheduled over 2000 clinical trial participants in less than 4 weeks (!) at low cost by integrating workflows in a vendor EHR! A short 🧵 (1/4)

Really nice article on the importance of hypertension control. Thank you @ACPIMPhysicians for featuring our work! Continue BP control, maintain benefits | I.M. Matters from ACP

🚨Federal claims data are critical to efforts to improve spending, quality, and equity in our health care system. In @JAMA_current, we wrote about how @CMSGov's data policy change may compromise these efforts — and recommended a better path forward. https://t.co/TQOUHsBweK 1/N

I can't wait to have @StatGirlLAM on campus! The only downside is I don't think we have time to go on a run together!

Improvement in cognitive function after kidney transplantation @KUJGKI @KUNeph @KUALZ